SBRT as a Vaccination for Metastatic Melanoma

NCT04042506 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unable to enroll patients in this study

Conditions

Metastatic Melanoma

Interventions

DRUG: Nivolumab 10 MG/ML Intravenous Solution [OPDIVO]
RADIATION: Stereotactic Body Radiation Therapy (SBRT)

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]